Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21(S1):16S–23S
CAS
PubMed
Google Scholar
Barbosa PCR, Giglio JS, Dalgalarrondo P (2005) Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. J Psychoactive Drugs 37(2):193–201
PubMed
Google Scholar
Barbosa PCR, Cazorla IM, Giglio JS, Strassman R (2009) A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects. J Psychoactive Drugs 41(3):205–212
PubMed
Google Scholar
Barbosa PCR, Strassman RJ, da Silveira DX, Areco K, Hoy R, Pommy J, Thoma R, Bogenschutz M (2016) Psychological and neuropsychological assessment of regular hoasca users. Compr Psychiatry 71:95–105
PubMed
Google Scholar
Barrett FS, Griffiths RR (2017a) The factor structure of the mystical experience questionnaire (MEQ): reply to Bouso et al., 2016. Hum Psychopharmacol Clin Exp 32(1):e2564
Google Scholar
Barrett FS, Griffiths RR (2017b) Classic hallucinogens and mystical experiences: phenomenology and neural correlates. In: Behavioral Neurobiology of Psychedelic Drugs. Springer, Berlin, Heidelberg, pp 393–430
Google Scholar
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57(1):289–300
Google Scholar
Berlowitz I, Walt H, Ghasarian C, Mendive F, Martin-Soelch C (2019) Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine. J Psychoactive Drugs:1–12
Bouso JC, Riba J (2014) Ayahuasca and the treatment of drug addiction. In: The Therapeutic Use of Ayahuasca. Springer, Berlin, Heidelberg, pp 95–109
Google Scholar
Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Barbosa PCR, Ángel Alcázar-Córcoles M, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J (2012) Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS One 7(8):e42421
CAS
PubMed
PubMed Central
Google Scholar
Bouso JC, Fábregas JM, Antonijoan RM, Rodríguez-Fornells A, Riba J (2013) Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology 230(3):415–424
CAS
PubMed
Google Scholar
Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A, Ribeiro S, Sanches R, Crippa JAS, Hallak JEC, de Araujo DB, Riba J (2015) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol 25(4):483–492
CAS
PubMed
Google Scholar
Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, ... & Hobden P (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci, 109(6), 2138–2143
Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen, M., Droog W, Murphy K, ... & Leech R (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci, 113(17), 4853–4858
Caspi A, Roberts BW, Shiner RL (2005) Personality development: stability and change. Annu Rev Psychol 56:453–484
Google Scholar
Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29(4):252
PubMed
PubMed Central
Google Scholar
Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50(12):975–990
CAS
Google Scholar
Clottes J, Lewis-Williams JD (1998) The shamans of prehistory: trance and magic in the painted caves. Harry N. Abrams, New York, pp 6–14
Google Scholar
Costa PT Jr, McCrae RR (2008) The NEO inventories. Personality Assessment 2:223–255
Google Scholar
Costa PT, McCrae RR (1992) Normal personality assessment in clinical practice: the NEO Personality Inventory. Psychol Assess 4(1):5–13
Google Scholar
Costandi, M. (2016). Neuroplasticity. MIT Press
de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JEC, Santos AC (2012) Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp 33(11):2550–2560
PubMed
Google Scholar
de Rios, M. D. (2009). The psychedelic journey of Marlene Dobkin de Rios: 45 years with shamans, ayahuasqueros, and ethnobotanists. Simon and Schuster
dos Santos RG (2013) A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. J Psychoactive Drugs 45(2):179–188
PubMed
Google Scholar
dos Santos RG, Hallak JEC (2019) Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience. Epilepsy Behav
dos Santos RG, & Strassman R (2008). Ayahuasca and psychosis. Br J Psychiatry 3
dos Santos RG, Balthazar FM, Bouso JC, Hallak JE (2016) The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol 30(12):1230–1247
PubMed
Google Scholar
dos Santos RG, Bouso JC, Hallak JE (2017) Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol 7(4):141–157
PubMed
PubMed Central
Google Scholar
Duggan C, Sham P, Lee A, Minne C, Murray R (1995) Neuroticism: a vulnerability marker for depression evidence from a family study. J Affect Disord 35(3):139–143
CAS
PubMed
Google Scholar
Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL (2018) Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand 138(5):368–378
CAS
PubMed
PubMed Central
Google Scholar
Fábregas JM, González D, Fondevila S, Cutchet M, Fernández X, Barbosa PCR, Alcázar-Córcoles MÁ, Barbanoj MJ, Riba J, Bouso JC (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111(3):257–261
PubMed
Google Scholar
Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, Pinto JP, Hallak JE, Zuardi AW, Crippa JA, Quevedo J (2009) Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry 33(8):1425–1430
CAS
Google Scholar
Gable RS (2007) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102(1):24–34
PubMed
Google Scholar
Gershon MD (2004) Serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20:3–14
CAS
PubMed
Google Scholar
Goldberg LR (1990) An alternative “description of personality”: the big-five factor structure. J Pers Soc Psychol 59(6):1216–1229
CAS
PubMed
Google Scholar
Gonzales VO (2006) Cento Espirita Beneficente União do Vegetal, 546, 418 (USA)
Grob CS, McKenna DJ, Callaway JC, Brito GS, Neves ES, Oberlaender G, Saide OL, Labigalini E, Tacla C, Miranda CT et al (1996) Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis 184:86–94
CAS
PubMed
Google Scholar
Hartogsohn I (2016) Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. J Psychopharmacol 30(12):1259–1267
CAS
PubMed
Google Scholar
Jang KL, Livesley WJ, Vernon PA (1996) Heritability of the big five personality dimensions and their facets: a twin study. J Pers 64(3):577–592
CAS
PubMed
Google Scholar
Kavenská V, Simonová H (2015) Ayahuasca tourism: participants in shamanic rituals and their personality styles, motivation, benefits and risks. J Psychoactive Drugs 47(5):351–359
PubMed
Google Scholar
Kotov R, Gamez W, Schmidt F, Watson D (2010) Linking “big” personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol Bull 136(5):768–821
PubMed
Google Scholar
Kuhl J, Kazén M (2009) Persönlichkeits-Stil-und Störungs-Inventar: PSSI; Manual. Hogrefe, Chicago
Google Scholar
Lackner N, Unterrainer HF, Neubauer AC (2013) Differences in Big Five personality traits between alcohol and polydrug abusers: implications for treatment in the therapeutic community. Int J Ment Heal Addict 11(6):682–692
Google Scholar
Luna LE (2011) Indigenous and mestizo use of ayahuasca: an overview. Ethnopharmacol Ayahuasca 2:1–21
Google Scholar
MacLean KA, Johnson MW, Griffiths RR (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol 25(11):1453–1461
CAS
PubMed
PubMed Central
Google Scholar
MacLean KA, Leoutsakos JMS, Johnson MW, Griffiths RR (2012) Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin. J Sci Study Relig 51(4):721–737
PubMed
PubMed Central
Google Scholar
Malouff JM, Thorsteinsson EB, Rooke SE, Schutte NS (2007) Alcohol involvement and the five-factor model of personality: a meta-analysis. J Drug Educ 37(3):277–294
PubMed
Google Scholar
Martin R, Watson D, Wan CK (2000) A three factor model of trait anger: dimensions of affect, behavior, and cognition. J Pers 68:869–897
CAS
PubMed
Google Scholar
McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther 102(2):111–129
CAS
PubMed
Google Scholar
McKenna DJ, Towers GN, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca. J Ethnopharmacol 10(2):195–223
CAS
PubMed
Google Scholar
Metzner R (Ed). (2005). Sacred mushroom of visions: Teonanacatl: a sourcebook on the psilocybin mushroom. Simon and Schuster
Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R (2018) 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry 5(6):486–497
PubMed
Google Scholar
Morales-Garcia JA, Echeverry-Alzate V, Alonso-Gil S, Sanz-SanCristobal M, Lopez-Moreno JA, Gil C, Martinez A, Santos A, Perez-Castillo A (2017) Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo. Stem Cells 35(2):458–472
CAS
Google Scholar
Nichols DE (2016) Psychedelics. Pharmacol Rev 68(2):264–355
CAS
PubMed
PubMed Central
Google Scholar
Osório FDL, Sanches RF, Macedo LR, Dos Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, ... & Hallak JE (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Braz J Psychiatry, 37(1), 13–20
Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JAS, Hallak JE, ... & de Araujo DB (2015). The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One, 10(2), e0118143
Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, ... & Tófoli LF (2019). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med, 49(4), 655–663
Prayag G, Mura P, Hall CM, Fontaine J (2016) Spirituality, drugs, and tourism: tourists’ and shamans’ experiences of ayahuasca in Iquitos, Peru. Tour Recreat Res 41(3):314–325
Google Scholar
Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 306(1):73–83
CAS
PubMed
Google Scholar
Riba J, Romero S, Grasa E, Mena E, Carrió I, Barbanoj MJ (2006) Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology 186(1):93–98
CAS
Google Scholar
Rivier L, Lindgren JE (1972) “Ayahuasca,” the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot 26(2):101–129
CAS
Google Scholar
Ruiz MA, Pincus AL, Schinka JA (2008) Externalizing pathology and the five-factor model: a meta-analysis of personality traits associated with antisocial personality disorder, substance use disorder, and their co-occurrence. J Personal Disord 22(4):365–388
Google Scholar
Sanches RF, de Lima Osório F, dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana, L, ... & Hallak JE (2016). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol, 36(1), 77–81
Santos RD, Landeira-Fernandez J, Strassman RJ, Motta V, Cruz APM (2007) Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J Ethnopharmacol 112(3):507–513
CAS
PubMed
Google Scholar
Schaefer SB (2006) Shamans, peyote, and coca sacraments: a path that maintains indigenous traditions and identity in a time of globalization. Cultura Y Droga 13:145–172
Google Scholar
Shanon B (2002) The antipodes of the mind: charting the phenomenology of the ayahuasca experience. Oxford University Press, Oxford
Google Scholar
Sessa B (2012) The psychedelic renaissance: reassessing the role of psychedelic drugs in 21st century psychiatry and society. Muswell Hill Press.
Stilo SA, Murray RM (2010) The epidemiology of schizophrenia: replacing dogma with knowledge. Dialogues Clin Neurosci 12(3):305–315
PubMed
PubMed Central
Google Scholar
Tafur J (2017). Fellowship of the river: a medical doctor’s exploration into traditional Amazonian plant medicine. Espiritu Books
Terracciano A, Löckenhoff CE, Crum RM, Bienvenu OJ, Costa PT (2008) Five-factor model personality profiles of drug users. BMC Psychiatry 8(1):22
PubMed
PubMed Central
Google Scholar
Terracciano A, McCrae RR, Costa PT Jr (2010) Intra-individual change in personality stability and age. J Res Pers 44(1):31–37
PubMed
PubMed Central
Google Scholar
Thomas G, Lucas P, Capler NR, Tupper KW, Martin G (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6(1):30–42
PubMed
Google Scholar
Tófoli LF (2011). An epidemiological surveillance system by the UDV: mental health recommendations concerning the religious use of hoasca. Int Ayahuasca (185-200)
Tupper KW (2009) Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice. Global Networks 9(1):117–136
Google Scholar
Turiano NA, Whiteman SD, Hampson SE, Roberts BW, Mroczek DK (2012) Personality and substance use in midlife: conscientiousness as a moderator and the effects of trait change. J Res Pers 46(3):295–305
PubMed
PubMed Central
Google Scholar
Winkelman M (2013) Shamanism in cross-cultural perspective. Int J Transp Stud 31(2):47–62
Google Scholar
Wolff TJ, Ruffell S, Netzband N, & Passie T (2019). A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism. J Psychedelic Stud, 1-13
Zinberg NE (1986) Drug, set, and setting: the basis for controlled intoxicant use. Yale University Press, Yale
Google Scholar